dronabinol has been researched along with 1-methyl-4-phenylpyridinium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, CB; Hanemann, CO; Zajicek, JP; Zeissler, ML | 1 |
| Duvigneau, JC; Kranner, B; Krewenka, C; Moldzio, R; Novak, J; Pacher, T; Rausch, WD | 1 |
| Carroll, CB; Eastwood, J; Hanemann, CO; McCorry, K; Zajicek, JP; Zeissler, ML | 1 |
3 other study(ies) available for dronabinol and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Herbicides; Humans; Neurons; Neuroprotective Agents; Oxidative Stress; Paraquat; Parkinson Disease; Receptor, Cannabinoid, CB1; Tumor Cells, Cultured; Up-Regulation | 2012 |
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Cannabidiol; Cannabis; Cells, Cultured; Dopaminergic Neurons; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Female; Free Radical Scavengers; Mesencephalon; Mice; Neuroprotective Agents; Pregnancy; Tyrosine 3-Monooxygenase | 2012 |
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis.
Topics: 1-Methyl-4-phenylpyridinium; Cell Line, Tumor; Dronabinol; Humans; Mitochondria; Mitochondrial Diseases; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pioglitazone; PPAR gamma; Thiazolidinediones | 2016 |